
    
      40 patients in each one of the three groups; In control group will receive normal saline,
      Intravenous Tranexamic acid group received 50 mg / kg intravenousely followed by of 1
      mg/kg/hr.for six hours. The topical Tranexamic acid group will have 50 mg / kg of tranexamic
      poured into the pericoredial cavity. in the first 24 hours we will measure the total blood
      loss and transfusion requirements. Complate blood picture and coagulation studies will be
      recorded. the occurrence of re-exploration for excess bleeding, or adverse events.
    
  